Regulatory & Legal

A new study confirms Theranica's migraine wearable won't disrupt glucose monitors, a major breakthrough for 4.5 million Americans with both conditions.

AgTech innovator Agroz Inc. faces a Nasdaq delisting warning. With 180 days to recover, its future hinges on balancing advanced tech with market realities.

A recent test saw an F-22 pilot command an unmanned drone using a tablet, showcasing a radical new future for air combat and U.S. air superiority.

A landmark ruling permanently bans infringing products, highlighting a fight over the future of AI/AR and raising urgent national security concerns.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

Blue Cross and Blue Shield of Kansas is the first health plan to earn URAC's new Health Equity Accreditation, setting a national precedent for accountability.

Armanino partners with Inflo, leveraging AI to offer clients real-time audit transparency and business insights, signaling a major industry shift.

A new animated video, voiced by a father and his daughter, offers hope and understanding to children battling a rare and life-threatening liver disease.

For the 11th straight year, OTAVA lands on CRN's prestigious MSP 500 list. We explore how its focus on security, compliance, and a human-first approach sets it apart.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

A 20-year fight to save Nova Scotia salmon from acid rain is now a certified climate technology, attracting major investment and creating a new model for conservation.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

Leading crypto ATM operator Bitcoin Depot now requires ID for every transaction, a move aimed at fighting fraud but raising questions about user access.

Facing SEC delays, Aptose Biosciences secures an $11.1M lifeline from its acquirer, Hanmi, highlighting financial strain as the critical deal moves forward.

Facing delisting, Hong Kong-based PTL Limited enacts a massive 1-for-80 share consolidation. But can this financial maneuver fix deeper business issues?

New data on MCO-010 gene therapy identifies ideal patients for Retinitis Pigmentosa, a key step as the one-time injection advances toward FDA approval.

After repeated hurricane shutdowns, St. Petersburg invests $1M in innovative flood panels to keep its critical water facilities running.

With no approved therapies for Hepatitis E, Atea Pharmaceuticals' new drug shows potent preclinical results, offering a potential lifeline for vulnerable patients.